Effects of Alitretinoin on Quality of Life of Patients Having Chronic Hand Eczema: An Observational Study

Year: 2013

Authors: Gola M., D’Erme A. M., Milanesi N., Marmugi L.

Autors Affiliation: University of Florence, Allergological and Occupational Dermatology, Department of Surgery and Translational Medicine, I-50100 Florence, Italy; University of Siena, CNISM, I-53100 Siena, Italy; University of Siena, Dept Phys, I-53100 Siena, Italy; Istituto Nazionale di Ottica CNR, Pisa, Italy

Abstract: Chronic hand eczema (CHE) is a common disease that has a major impact on patients’ health and on society. Aim The purpose of this observational, open-label study was to assess the efficacy of treatment with 30 mg/d of oral alitretinoin on the quality of life (QoL) in a group of patients affected by CHE. Methods This study included 15 patients, all suffering from severe CHE refractory to treatment with potent topical corticosteroids, who underwent treatment with 30 mg/d of alitretinoin for a period of 3 months. At the 1- and 3-month points, together with a clinical evaluation, the QoL of these patients were evaluated by the Dermatology Life Quality Index and visual analog scale (EQ5D-VAS). Results The oral administration of alitretinoin led to a notable QoL improvement among the patients, as shown by the statistically significant improvement in the Dermatology Life Quality Index and in the EQ5D-VAS after 1 and 3 months of therapy.

Journal/Review: DERMATITIS

Volume: 24 (4)      Pages from: 166  to: 169

KeyWords: Alitretinoin; Chronic Hand Eczema;
DOI: 10.1097/DER.0b013e3182987773

Citations: 9
data from “WEB OF SCIENCE” (of Thomson Reuters) are update at: 2024-11-17
References taken from IsiWeb of Knowledge: (subscribers only)
Connecting to view paper tab on IsiWeb: Click here
Connecting to view citations from IsiWeb: Click here